A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma (NCT04162015)

🧪 Interventions in This Study

• Nivolumab (DRUG)
• Pemetrexed (DRUG)
• Cisplatin or Carboplatin (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (7 Sites)

• Memoiral Sloan Kettering Basking Ridge — Basking Ridge, New Jersey
• Memorial Sloan Kettering Monmouth — Middletown, New Jersey
• Memorial Sloan Kettering Bergen — Montvale, New Jersey
• Memorial Sloan Kettering Commack — Commack, New York
• Memorial Sloan Kettering Westchester — Harrison, New York
• Memorial Sloan Kettering Cancer Center — New York, New York
• Memorial Sloan Kettering Nassau — Uniondale, New York

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Malignant Pleural Mesothelioma

• A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma — Basking Ridge, New Jersey
• OT-101 in Combination With Pembrolizumab in Subjects With Malignant Pleural Mesothelioma Failing to Respond to Checkpoint Inhibition — Philadelphia, Pennsylvania
• Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma — Basking Ridge, New Jersey

Explore by condition: All Malignant Pleural Mesothelioma clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.